The latest study report shows that B4GALT1 is a newly discovered PD-L1 glycosyltransferase, and in triple-negative breast cancer, RBMS1 can bind to the 3′-UTR of B4GALT1 to stabilize its mRNA. Here, RBMS1 is linked to triple-negative breast carcinoma.